• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过颗粒酶B PET成像监测的氧气输送纳米颗粒增强恶性肿瘤免疫治疗疗效。

Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.

作者信息

Wang Xingyi, Fang Hanyi, Hu Wenzhu, Feng Yuan, Zhou Zhangyongxue, Hu Mengyan, Jiang Dawei, Zhang Yongxue, Lan Xiaoli

机构信息

Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Hubei Province Key Laboratory of Molecular Imaging, 1277 Jiefang Avenue, Wuhan, 430022, China.

出版信息

J Nanobiotechnology. 2025 Mar 7;23(1):186. doi: 10.1186/s12951-025-03257-6.

DOI:10.1186/s12951-025-03257-6
PMID:40050894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11887188/
Abstract

Limited treatment response and inadequate monitoring methods stand firmly before successful immunotherapy. Recruiting and activating immune cells in the hypoxic tumor microenvironment is the key to reversing immune suppression and improving immunotherapy efficacy. In this study, biomimetic oxygen-delivering nanoparticles (CmPF) are engineered for homologous targeting and hypoxia alleviation within the tumor environment. CmPF targets the tumor microenvironment and delivers oxygen to reduce hypoxia, thereby promoting immune cell activity at the tumor site. In addition, granzyme B-targeted positron emission tomography (PET) imaging is employed to monitor immune cell activity changes in response to immunotherapy efficacy in vivo. The combination of CmPF with carboplatin and PD-1 inhibitors significantly suppresses tumor growth by 2.4-fold, exhibiting the potential of CmPF to enhance the efficacy of immunotherapy. Immunohistochemistry further confirms increased expression of key immune markers, highlighting the reprogramming of the tumor microenvironment. This study demonstrates that hypoxia alleviation enhances tumor immunotherapy efficacy and introduces a non-invasive PET imaging method for dynamic, real-time assessment of therapeutic response.

摘要

有限的治疗反应和不完善的监测方法是成功进行免疫治疗面临的严峻挑战。在缺氧的肿瘤微环境中招募和激活免疫细胞是逆转免疫抑制和提高免疫治疗效果的关键。在本研究中,我们设计了仿生输氧纳米颗粒(CmPF),用于在肿瘤环境中进行同源靶向和缓解缺氧。CmPF靶向肿瘤微环境并输送氧气以减轻缺氧,从而促进肿瘤部位的免疫细胞活性。此外,采用靶向颗粒酶B的正电子发射断层扫描(PET)成像来监测体内免疫细胞活性因免疫治疗效果而发生的变化。CmPF与卡铂和PD-1抑制剂联合使用可显著抑制肿瘤生长达2.4倍,显示出CmPF增强免疫治疗效果的潜力。免疫组织化学进一步证实关键免疫标志物的表达增加,突出了肿瘤微环境的重编程。本研究表明,缓解缺氧可提高肿瘤免疫治疗效果,并引入了一种非侵入性PET成像方法用于动态、实时评估治疗反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/9fe0117d2811/12951_2025_3257_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/5ced6227cb32/12951_2025_3257_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/abc34a238505/12951_2025_3257_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/cee38243fcb2/12951_2025_3257_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/33e03a8d901b/12951_2025_3257_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/6044adce9c3d/12951_2025_3257_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/380cdec7bcb4/12951_2025_3257_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/9fe0117d2811/12951_2025_3257_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/5ced6227cb32/12951_2025_3257_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/abc34a238505/12951_2025_3257_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/cee38243fcb2/12951_2025_3257_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/33e03a8d901b/12951_2025_3257_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/6044adce9c3d/12951_2025_3257_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/380cdec7bcb4/12951_2025_3257_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23c6/11887188/9fe0117d2811/12951_2025_3257_Fig7_HTML.jpg

相似文献

1
Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.通过颗粒酶B PET成像监测的氧气输送纳米颗粒增强恶性肿瘤免疫治疗疗效。
J Nanobiotechnology. 2025 Mar 7;23(1):186. doi: 10.1186/s12951-025-03257-6.
2
Utilizing PET Imaging To Visualize Immune Activation and Tumor Apoptosis.利用正电子发射断层扫描(PET)成像技术可视化免疫激活和肿瘤细胞凋亡。
Mol Pharm. 2025 Apr 7;22(4):2122-2130. doi: 10.1021/acs.molpharmaceut.4c01314. Epub 2025 Mar 25.
3
Granzyme B PET imaging of immune-mediated tumor killing as a tool for understanding immunotherapy response.颗粒酶B正电子发射断层扫描成像用于免疫介导的肿瘤杀伤,作为理解免疫治疗反应的一种工具。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2019-000291.
4
A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.一种新型的颗粒酶 B 纳米颗粒递药系统模拟免疫细胞功能,抑制实体瘤。
Theranostics. 2019 Oct 14;9(25):7616-7627. doi: 10.7150/thno.35900. eCollection 2019.
5
Development of Granzyme B-targeted Smart Positron Emission Tomography Probes for Monitoring Tumor Early Response to Immunotherapy.基于 Granzyme B 的智能正电子发射断层扫描探针用于监测肿瘤对免疫治疗早期反应的开发。
ACS Nano. 2024 Jul 23;18(29):18910-18921. doi: 10.1021/acsnano.4c01157. Epub 2024 Jul 13.
6
[F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response.FMISO-PET 成像揭示了缺氧严重程度在检查点阻断反应中的作用。
Nucl Med Biol. 2024 Jul-Aug;134-135:108918. doi: 10.1016/j.nucmedbio.2024.108918. Epub 2024 May 8.
7
Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.利用 pH 响应性杂化膜包覆纳米粒子调控免疫抑制性肿瘤微环境以增强乳腺癌免疫治疗。
J Nanobiotechnology. 2021 Feb 25;19(1):58. doi: 10.1186/s12951-021-00805-8.
8
Oxygen/siRNA-carrying fluoro-nanosensitizers for radio-immunotherapy sensitization.用于放射免疫治疗增敏的载氧/小干扰RNA氟纳米敏化剂
Acta Biomater. 2025 Apr;196:423-435. doi: 10.1016/j.actbio.2025.03.011. Epub 2025 Mar 7.
9
Enhancing the tissue penetration to improve sonodynamic immunotherapy for pancreatic ductal adenocarcinoma using membrane-camouflaged nanoplatform.利用膜伪装纳米平台增强组织穿透性以改善胰腺导管腺癌的声动力免疫治疗
Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):1119-1136. doi: 10.1007/s00259-024-06952-y. Epub 2024 Oct 18.
10
Ultrasound -Induced Thermal Effect Enhances the Efficacy of Chemotherapy and Immunotherapy in Tumor Treatment.超声诱导热效应增强肿瘤治疗中的化疗和免疫治疗效果。
Int J Nanomedicine. 2024 Jul 3;19:6677-6692. doi: 10.2147/IJN.S464830. eCollection 2024.

引用本文的文献

1
Advancements in Tumor-Targeted Nanoparticles: Design Strategies and Multifunctional Therapeutic Approaches.肿瘤靶向纳米颗粒的进展:设计策略与多功能治疗方法
Nanomaterials (Basel). 2025 Aug 15;15(16):1262. doi: 10.3390/nano15161262.
2
Enhancing photodynamic therapy for cutaneous squamous cell carcinoma with ACP-U soluble microneedles.使用ACP-U可溶性微针增强皮肤鳞状细胞癌的光动力疗法。
iScience. 2025 May 27;28(6):112766. doi: 10.1016/j.isci.2025.112766. eCollection 2025 Jun 20.

本文引用的文献

1
Biomimetic Single-Atom Nanozyme for Dual Starvation-Enhanced Breast Cancer Immunotherapy.用于双重饥饿增强型乳腺癌免疫治疗的仿生单原子纳米酶
Adv Healthc Mater. 2025 Mar;14(8):e2401362. doi: 10.1002/adhm.202401362. Epub 2024 Oct 3.
2
Bionic aggregation-induced emission photosensitizer for enhanced cancer immunotherapy.用于增强癌症免疫治疗的仿生聚集诱导发光光敏剂
Mater Today Bio. 2024 Aug 24;28:101217. doi: 10.1016/j.mtbio.2024.101217. eCollection 2024 Oct.
3
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
SAPPHIRE 研究:西他拉替尼联合纳武利尤单抗对比多西他赛用于晚期非鳞状非小细胞肺癌。
Ann Oncol. 2024 Jan;35(1):66-76. doi: 10.1016/j.annonc.2023.10.004. Epub 2023 Oct 20.
4
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1.三十年探索的见解:PD1的功能、调节及治疗调控
Nat Rev Immunol. 2023 Oct;23(10):682-695. doi: 10.1038/s41577-023-00867-9. Epub 2023 Apr 25.
5
Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge.载 I 型 AIE 光敏剂仿生体系增强铜死亡以抑制乳腺癌转移和再挑战
ACS Nano. 2023 Jun 13;17(11):10206-10217. doi: 10.1021/acsnano.3c00326. Epub 2023 May 15.
6
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.美国国立综合癌症网络(NCCN)指南见解:非小细胞肺癌,2023年第2版
J Natl Compr Canc Netw. 2023 Apr;21(4):340-350. doi: 10.6004/jnccn.2023.0020.
7
Emerging phagocytosis checkpoints in cancer immunotherapy.癌症免疫治疗中的新兴吞噬检查点。
Signal Transduct Target Ther. 2023 Mar 7;8(1):104. doi: 10.1038/s41392-023-01365-z.
8
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions.缺氧微环境与癌症:分子机制与治疗干预。
Signal Transduct Target Ther. 2023 Feb 17;8(1):70. doi: 10.1038/s41392-023-01332-8.
9
Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab.免疫检查点抑制剂的替代剂量策略以提高成本效益:特别关注纳武利尤单抗和帕博利珠单抗。
Lancet Oncol. 2022 Dec;23(12):e552-e561. doi: 10.1016/S1470-2045(22)00554-X.
10
Immunogenic cell stress and death.免疫原性细胞应激和死亡。
Nat Immunol. 2022 Apr;23(4):487-500. doi: 10.1038/s41590-022-01132-2. Epub 2022 Feb 10.